A safe and effective rotavirus vaccine is urgently needed, particularly in developing
countries. Critical to vaccine development and implementation is a knowledge base …

The development and implementation of safe and effective vaccines to prevent the
enormous health burden of rotavirus-associated disease is a global public health goal …

ABSTRACT We characterized 1,534 rotavirus (RV) strains collected in Bangladesh from
1992 to 1997 to assess temporal changes in G type and to study the most common G and P …

In a 2-year study of viral gastroenteritis in children in Blantyre, Malawi, the diversity of
rotavirus strains was investigated by using electropherotyping, reverse transcription-PCR …

The efficacy of licensed rotavirus vaccines has only been shown against certain rotavirus
group A (RV‐A) types. It is critical to understand the burden of rotavirus gastroenteritis …

The prevalence and type diversity of human astroviruses (HAstV) in children with
symptomatic and asymptomatic infections were determined in five localities of Mexico …

After the introduction of monovalent rotavirus vaccine (RV1) in Mexico in 2006–2007,
diarrhea mortality and morbidity declined substantially among Mexican children under 5 …

ABSTRACT The P (VP4) and G (VP7) genotypes of 167 group A rotavirus strains obtained
during the period 1996 to 1998 from 149 children living in a suburban community in Guinea …

Abstract The G1P1A [8] rotavirus vaccine candidate 89‐12, the precursor to Rotarix,
stimulated high titers of neutralizing antibodies to non‐G1/P1A [8] serotypes of human …

We studied in the rotavirus system whether the internal protein VP6 could prime for an
enhancement in the production of neutralizing antibodies (NeuAb) against the external …